Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2023 No.23

Total 15 articles

Mechanisms and clinical research progress in oncotherapy of trilaciclib,a cyclin-dependent kinase 4/6 inhibitorZHENG Xue-qing, ZHANG Li, ZHANG Xiao-tong

2329-2338

Mechanism of action and clinical research progress of trilaciclib in bone marrow protectionQIAN Min-jia, JIN Ge, FU Ling-ling, XU Min, CHEN He-jian, ZHOU Jian-ying, CHEN Pei-feng

2339-2346

Research progresses and frontiers of chemotherapy-induced myelosuppression in small-cell lung cancerWU Yu-feng, YU Li-meng, ZHAO Yu-hua, WANG Qi-ming

2347-2353

Pharmacoeconomics of trilaciclib in the prevention of chemotherapy-induced myelosuppressionLEI Wei-cheng, GUO Chen-chen, DU Bao-ping, LIU Tao, LIANG Wei-ting

2354-2359

Trilaciclib combined with topotecan as second-line treatment for extensive-stage small-cell lung cancer:a case report and literature reviewYUAN Jing, LU Wei-ping, XIAO Guo-dong, FAN Hui-jie

2360-2365

First-line trilaciclib combined with immunotherapy plus chemotherapy for extensive-stage small-cell lung cancer:a case report and literature reviewREN Guan-ying, SONG Zi-zheng, WANG Xiao-lei, HU Ling, SONG Jin

2366-2369

Trilaciclib combined with immunotherapy and chemotherapy for treatment of advanced esophageal cancer:a case report and literature reviewYAN Jing-ze, CHEN Hui, GE Xiao-lin, XIA Xiao-jie

2370-2374

Patent information analysis of global antitumor drugsZHANG Jing, LI Jing, HU Jie

2375-2384

Chinese patent analysis of multi-target tyrosine kinase inhibitor regorafenibHONG Meng-shi, LI You

2385-2393

Progress in target discovery and drug development for non-alcohol fatty liver diseaseSUN Zhao-hui, YANG Zhen-zheng, ZHENG Xiao-nan

2394-2402